Trace analysis of fluoxetine and its metabolite norfluoxetine. Part II: Enantioselective quantification and studies of matrix effects in raw and treated wastewater by solid phase extraction and liquid chromatography-tandem mass spectrometry

Journal of Chromatography A

Volumn 1227, Issue , 2012, Pages 105-114

  Barclay, Victoria K H ^a   Tyrefors, Niklas L ^a   Johansson, I Monika ^a,b   Pettersson, Curt E ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b MEDICAL PRODUCTS AGENCY   (Sweden)

Author keywords

Chiral analysis; Fluoxetine and norfluoxetine; Isotope labeled compound; LC MS MS; Matrix effects; Wastewater

Indexed keywords

CHIRAL ANALYSIS; FLUOXETINE; ISOTOPE-LABELED COMPOUND; LC-MS/MS; MATRIX EFFECTS;

BIOMOLECULES; CHIRALITY; DRUG PRODUCTS; ENANTIOMERS; ISOTOPES; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; METABOLITES; TRACE ANALYSIS; WASTEWATER;

WASTEWATER TREATMENT;

FLUOXETINE; NORFLUOXETINE;

ACCURACY; ARTICLE; CALIBRATION; CHIRAL CHROMATOGRAPHY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; ELUTION; ENANTIOMER; ENANTIOSELECTIVITY; IONIZATION; ISOTOPE LABELING; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MOLECULAR INTERACTION; PHASE TRANSITION; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS; WASTE WATER MANAGEMENT;

CALIBRATION; CHROMATOGRAPHY, LIQUID; DEUTERIUM; FLUOXETINE; REPRODUCIBILITY OF RESULTS; SEWAGE; SOLID PHASE EXTRACTION; STEREOISOMERISM; TANDEM MASS SPECTROMETRY; WATER POLLUTANTS, CHEMICAL;

EID: 84856605475     PISSN: 00219673     EISSN: 18733778     Source Type: Journal    
DOI: 10.1016/j.chroma.2011.12.084     Document Type: Article

References (37)

1. Oakes K.D., Coors A., Escher B.I., Fenner K., Garric J., Gust M., Knacker T., Küster A., Kussatz C., Metcalfe C.D., Monteiro S., Moon T.W., Mennigen J.A., Parrott J., Péry A.R.R., Ramil M., Roennefahrt I., Tarazona J.V., Sánchez-Argüello P., Ternes T.A., Trudeau V.L., Boucard T., Van Der Kraak G.J., Servos M.R. Integr. Environ. Assess. Manag. 2010, 6:524.
2. van Nuijs A.L.N., Tarcomnicu I., Simons W., Bervoets L., Blust R., Jorens P.G., Neels H., Covaci A. Anal. Bioanal. Chem. 2010, 398:2211.
3. MacLeod S.L., Sudhir P., Wong C.S. J. Chromatogr. A 2007, 1170:23.
4. Lajeunesse A., Gagnon C., Sauvé S. Anal. Chem. 2008, 80:5325.
5. Vasskog T., Anderssen T., Pedersen-Bjergaard S., Kallenborn R., Jensen E. J. Chromatogr. A 2008, 1185:194.
6. Heberer T. Toxicol. Lett. 2002, 131:5.
7. Ternes T.A. Water Res. 1998, 32:3245.
8. Gros M., Petrović M., Barceló D. Anal. Chem. 2009, 81:898.
9. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., Buxton H.T. Environ. Sci. Technol. 2002, 36:1202.
10. Benotti M.J., Trenholm R.A., Vanderford B.J., Holady J.C., Stanford B.D., Snyder S.A. Environ. Sci. Technol. 2009, 43:597.
11. Wong C. Anal. Bioanal. Chem. 2006, 386:544.
12. King R., Bonfiglio R., Fernandez-Metzler C., Miller-Stein C., Olah T. J. Am. Soc. Mass Spectrom. 2000, 11:942.
13. Viswanathan C.T., Bansal S., Booth B., DeStefano A., Rose M.J., Sailstad J., Shah V.P., Skelly J.P., Swann P.G., Weiner R. Pharm. Res. 2007, 24:1962.
14. Sojo L.E., Lum G., Chee P. Analyst 2003, 128:51.
15. Fuller R.W., Snoddy H.D., Krushinski J.H., Robertson D.W. Neuropharmacology 1992, 31:997.
16. Stanley J.K., Ramirez A.J., Chambliss C.K., Brooks B.W. Chemosphere 2007, 69:9.
17. De Andrés F., Castañeda G., Ríos á. Chirality 2009, 21:751.
18. Fono L.J., Sedlak D.L. Environ. Sci. Technol. 2005, 39:9244.
19. Hashim N.H., Shafie S., Khan S.J. Environ. Technol. 2010, 31:1349.
20. Poiger T., Buser H.-R., Müller M.D., Balmer M.E., Buerge I.J. Chimia 2003, 57:492.
21. Barclay V.K.H., Tyrefors N.L., Johansson I.M., Pettersson C.E. J. Chromatogr. A 2011, 1218:5587.
22. Buser H.-R., Poiger T., Müller M.D. Environ. Sci. Technol. 1999, 33:2529.
23. Wong D.T., Baymaster F.P., Reid L.R., Fuller R.W., Perry K.W. Drug Dev. Res. 1985, 6:397.
24. Wong D.T., Bymaster F.P., Reid L.R., Mayle D.A., Krushinski J.H., Robertson D.W. Neuropsychopharmacology 1993, 8:337.
25. Bonfiglio R., King R.C., Olah T.V., Merkle K. Rapid Commun. Mass Spectrom. 1999, 13:1175.
26. Buhrman D.L., Price P.I., Rudewicz P.J. J. Am. Soc. Mass Spectrom. 1996, 1099.
27. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Anal. Chem. 2003, 75:3019.
28. Liang H.R., Foltz R.L., Meng M., Bennett P. Rapid Commun. Mass Spectrom. 2003, 17:2815.
29. Freitas L.G., Götz C.W., Ruff M., Singer H.P., Müller S.R. J. Chromatogr. A 2004, 1028:277.
30. Magnér J.A., Alsberg T.E., Broman D. Anal. Bioanal. Chem. 2009, 395:1481.
31. Harner T., Wiberg K., Norstrom R. Environ. Sci. Technol. 2000, 34:218.
32. Peters F.T., Maurer H.H. Anal. Chem. 2007, 79:4967.
33. Mechlinska A., Wolska L., Namiesnik J. TrAC Trends Anal. Chem. 2010, 29:820.
34. Carballa M., Omil F., Lema J.M. Chemosphere 2008, 72:1118.
35. Guidance for Industry Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), Rockville, 2001.
36. Matamoros V., Hijosa M., Bayona J.M. Chemosphere 2009, 75:200.
37. Torok-Both G.A., Baker G.B., Coutts R.T., McKenna K.F., Aspeslet L.J. J. Chromatogr. 1992, 579:99.